SCHEMBL20008234

SCHEMBL20008234

CNc1nc(C)cc(-c2ccccc2C)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.49
CYP2C19 P33261 5/20 0.49
CYP2D6 P10635 5/20 0.49
HSD17B10 Q99714 4/20 0.49
CLK4 Q9HAZ1 3/20 0.49
ALOX15 P16050 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
ALDH1A1 P00352 4/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP3A4 P08684 5/20 0.41
SDHB P21912 1/20 0.41
PTPN1 P18031 1/20 0.41
NUDT1 P36639 2/20 0.41
HSP90AA1 P07900 1/20 0.40
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
IDO1 P14902 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24326363 0.81 TDP1 (0.46) TDP1ALDH1A1NPC1RAB9ANUDT1
SCHEMBL18508365 0.74 TP53 (0.43) CYP1A2CYP2C19CYP2D6HSD17B10CLK4
SCHEMBL9827717 0.74 TUBB4A (0.55) CYP1A2CYP2C19CYP2D6HSD17B10ALOX15
SCHEMBL22174077 0.74 HSD17B10 (0.57) CYP1A2CYP2C19CYP2D6HSD17B10CLK4
SCHEMBL3266109 0.72 MAPT (0.53) TDP1ALDH1A1MAPK1MEN1KMT2A
SCHEMBL805593 0.71 CRHR1 (0.47) CYP1A2CYP2C19CYP2D6HSD17B10CLK4
SCHEMBL30928311 0.70 ENPP3 (0.43) CYP1A2CYP2C19CYP2D6HSD17B10CLK4
SCHEMBL23468767 0.70 ENPP3 (0.43) CYP1A2CYP2C19CYP2D6HSD17B10CLK4
SCHEMBL9827709 0.70 AURKA (0.52) CYP1A2CYP2C19HSD17B10ALOX15TDP1
SCHEMBL15757363 0.70 NUDT1 (0.78) CYP1A2CYP2C19CYP2D6HSD17B10CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3299367-A1 BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS Novartis AG (CH) 2018-03-28 EP disclosed